Skip to main content

Advertisement

SpringerLink
Log in

Immunologic reconstitution in 22q deletion (DiGeorge) syndrome

  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

Adoptive transfer of mature T cells (ATMTC) through bone marrow (BM) transplantation, first attempted over 20 years ago, has recently emerged as a successful therapy for complete 22q deletion syndrome (22qDS). This provides a potential option to thymic transplantation (TT) for immune reconstitution in 22qDS. Compared to thymic transplant, ATMTC is an easier procedure to accomplish and is available at more centers. However, there are differences in the nature of the T-cell reconstitution that results. Predictably, more naïve T cells and recent thymic emigrants are present in patients treated with thymus transplant. There are no significant differences in mortality between the two procedures, but the number of patients is too limited to conclude that the procedures are equally effective. Adoptive transfer should be pursued as a reasonable treatment for 22qDS patients requiring immune reconstitution when thymus transplant is not available.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Sullivan K. The clinical, immunological and molecular spectrum of chromosome 22q11.2 deletion syndrome and DiGeorge syndrome. Curr Opin Allergy Clin Immunol. 2004;4:505–12.

    Article  PubMed  Google Scholar 

  2. Markert ML, Alexieff MJ, Li J, Sarzotti M, Ozaki DA, Devlin BH, et al. Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome. Blood. 2004;104:2574–81.

    Article  PubMed  CAS  Google Scholar 

  3. Rice H, Skinner M, Mahaffey K, Oldham R, Ing L, Hale M, et al. Thymic transplantation for complete DiGeorge syndrome: medical and surgical considerations. J Pediatr Surg. 2004;39:1607–15.

    Article  PubMed  Google Scholar 

  4. Markert ML, Boeck A, Hale L, Kloster AL, McLaughlin TM, Batchvarova MN. Transplantation of thymus tissue in complete DiGeorge syndrome. New Engl J Med. 1999;341:1180–9.

    Article  PubMed  CAS  Google Scholar 

  5. Markert ML, Sarzotti M, Ozake DA, Sempowski GD, Rhein ME, Hale LP. Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients. Blood. 2003;102:1121–30.

    Article  PubMed  CAS  Google Scholar 

  6. Markert ML, Devlin BH, Alexieff MJ, Li J, McCarthy EA, Gupton SE, et al. Review of 54 patients with compete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants. Blood. 2007;109:4539–47.

    Article  PubMed  CAS  Google Scholar 

  7. Chinn IK, Devlin BH, Li Y, Markert ML. Long-term tolerance to allogeneic thymus transplants in complete DiGeorge anomaly. Clin Immunol. 2007;126:277–81.

    Article  PubMed  Google Scholar 

  8. Ku CC, Murakami M, Sakamoto A, Kappler J, Marrack P. Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science. 2000;288:675–8.

    Article  PubMed  CAS  Google Scholar 

  9. Tan JT, et al. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci USA. 2001;98:8732–7.

    Article  PubMed  CAS  Google Scholar 

  10. Schluns KS, Kieper WC, Jameson SC, Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol. 2000;1:426–32.

    Article  PubMed  CAS  Google Scholar 

  11. Goldrath AW, et al. Cytokine requirements for acute and basal homeostatic proliferation of naive and memory CD8+ T cells. J Exp Med. 2002;195:1515–22.

    Article  PubMed  CAS  Google Scholar 

  12. Seddon B, Tomlinson P, Zamoyska R. Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat Immunol. 2003;4:680–6.

    Article  PubMed  CAS  Google Scholar 

  13. Alves NL, Hooibrink B, Arosa FA, van Lier RA. IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T cells in vitro. Blood. 2003;102:2541–6.

    Article  PubMed  CAS  Google Scholar 

  14. Tan JT, et al. Interleukin (IL)–15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp Med. 2002;195:1523–32.

    Article  PubMed  CAS  Google Scholar 

  15. Land MH, Garcia-Lloret MI, Borzy MS, Rao PN, Aziz N, McGhee SA. Long-term results of bone marrow transplantation in complete DiGeorge syndrome. J Allergy Clin Immunol. 2007;120:908–15.

    Article  PubMed  CAS  Google Scholar 

  16. Daguindau N, Decot V, Nzietchueng R, Ferrand C, Picard C, Latger-Cannard V, et al. Immune constitution monitoring after PBMC transplantation in complete DiGeorge syndrome: an eight-year follow-up. Clin Immunol. 2008;128:164–71.

    Article  PubMed  CAS  Google Scholar 

  17. Goldsobel A, Haas A, Steihm E. Bone marrow transplantation in DiGeorge syndrome. J Pediatr. 1987;111:40–4.

    Article  PubMed  CAS  Google Scholar 

  18. Borzy M, Ridgway D, Noya F, Shearer W. Successful bone marrow transplantation with split lymphoid chimerism in DiGeorge syndrome. J Clin Immunol. 1989;9:386–92.

    Article  PubMed  CAS  Google Scholar 

  19. Matsumoto T, Anamoto N, Kondoh T, Nakayama M, Takayanagi T, Tsuji Y. Complete-type DiGeorge syndrome treated by bone marrow transplantation. Bone Marrow Transplant. 1998;22:927–30.

    Article  PubMed  CAS  Google Scholar 

  20. Bensoussan D, Le Deist F, Latger-Cannard V, Gergoire M, Avinens O, Feugier P, et al. T-cell immune constitution after peripheral blood mononuclear cell transplantation in complete DiGeorge syndrome. Br J Haematol. 2002;117:899–906.

    Article  PubMed  CAS  Google Scholar 

  21. Ohtsuka Y, Shimizu T, Nishizawa K, Ohtaki R, Someya T, Noguchi A, et al. Successful engraftment and decrease of cytomegalovirus load after cord blood stem cell transplantation in a patient with DiGeorge syndrome. Eur J Pediatr. 2004;163:747–8.

    Article  PubMed  Google Scholar 

  22. Hoenig M, Schulz A, Schuetz C, Debatin K, Friedrich W. Treatment of complete DiGeorge syndrome by repeat transfusions of blood lymphocytes from an HLA-identical sibling donor. Poster presentation 486, American Society of Hematology 46th Annual Meeting, December 4, 2004; San Diego, CA.

  23. Al-Tamemi S, Mazer B, Mitchell D, Albuquerque P, Duncan A, McCusker C, et al. Complete DiGeorge anomaly in the absence of neonatal hypocalcemia and velofacial and cardiac defects. Pediatrics. 2005;116:e457–60.

    Article  PubMed  Google Scholar 

  24. Janda A, Sedlacek P, Mejstrikova E, Zdrahalova K, Hrusak O, Kalina T, et al. Unrelated partially matched lymphocyte infusions in a patient with complete DiGeorge/CHARGE syndrome. Pediatr Transplant. 2007;11:441–7.

    Article  PubMed  Google Scholar 

  25. Markert ML. Treatment of infants with complete DiGeorge anomaly. J Allergy Clin Immunol. 2008;121:1063.

    Article  PubMed  Google Scholar 

  26. Markert ML, Alexieff MJ, Li J, Sarzotti M, Ozaki DA, Devlin BH, et al. Complete DiGeorge syndrome: development of rash, lymphadenopathy, and oligoclonal T cells in 5 cases. J Allergy Clin Immunol. 2004;113:734–41.

    Article  PubMed  CAS  Google Scholar 

  27. Gennery AR, Barge D, O’Sullivan JJ, Flood TJ, Abinun M, Cant AJ. Antibody deficiency and autoimmunity in 22q112 deletion syndrome. Arch Dis Child. 2002;86:422–5.

    Article  PubMed  CAS  Google Scholar 

  28. Davies JK, Telfer P, Cavenagh JD, Foot N, Neat M. Autoimmune cytopenias in the 22q11.2 deletion syndrome. Clin Lab Haematol. 2003;25:195–7.

    Article  PubMed  CAS  Google Scholar 

  29. Bale PM, Sotelo-Avila C. Maldescent of the thymus: 34 necropsy and 10 surgical cases, including 7 thymuses medial to the mandible. Pediatr Pathol. 1993;13:181–90.

    Article  PubMed  CAS  Google Scholar 

  30. Wilson DI, Burn J, Scambler P, Goodship J. George syndrome: part of CATCH 22. J Med Genet. 1993;30:852–6.

    Article  PubMed  CAS  Google Scholar 

  31. Jawad AF, McDonald-McGinn DM, Zackai E, Sullivan KE. Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). J Pediatr. 2001;139:715–23.

    Article  PubMed  CAS  Google Scholar 

  32. Piliero LM, Sanford AN, McDonald-McGinn DM, Zackai EH, Sullivan KE. T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q112 deletion syndrome. Blood. 2004;103:1020–5.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Division of Pediatric Immunology, David Geffen School of Medicine at UCLA, MDCC 12-430, Los Angeles, CA, 90095-1752, USA

    Sean A. McGhee, Maria Garcia Lloret & E. Richard Stiehm

Authors
  1. Sean A. McGhee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Garcia Lloret
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Richard Stiehm
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria Garcia Lloret.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McGhee, S.A., Lloret, M.G. & Stiehm, E.R. Immunologic reconstitution in 22q deletion (DiGeorge) syndrome. Immunol Res 45, 37–45 (2009). https://doi.org/10.1007/s12026-009-8108-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12026-009-8108-7

Keywords

Search

Navigation